Research and Training Funding

Funding Opportunity Announcements

Browse below for Data Science Funding Opportunity Announcements.

This page last reviewed on August 7, 2019

Feed last updated: February 17 2020 6:51 am
Title FOA Number Organization Release Date Expiration Date Purpose Search Terms
Notice of NIH/BD2K Participation in the Joint NSF/NIH Initiative on Quantitative Approaches to Biomedical Big Data (QuBBD) NOT-EB-16-008 NIBIB Jul 05 2016 N/A Notice NIH/BD2K Participation the Joint NSF/NIH Initiative Quantitative Approaches Biomedical Big Data QuBBD) Notice Number: NOT-EB-16-008 Key Dates Release Date: July 5, 2016 Related Announcements NOT-RM-17-012 NOT-AI-16-070 Issued National Institutes Health NIH) National Cancer Institute NCI) National Eye Institute NEI) National Heart, Lung, Blood Institute NHLBI) National Human Genome Research Institute NHGRI) National Institute Aging NIA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Library Medicine NLM) National Center Complementary Integrative Health NCCIH) National Center Advancing Translational Sciences NCATS) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Office Strategic Coordination Common Fund) Purpose Biomedical research rapidly becoming data-intensive investigators generating using increasingly large, complex, multidimensional, diverse datasets. era big data biomedical research taxes ability many researchers release, locate, analyze, interact these data associated software due the lack tools, accessibility, training. response these new challenges biomedical research, in response the recommendations the Data Informatics Working Group DIWG) the Advisory Committee the NIH Director http://acd.od.nih.gov/diwg.htm), NIH launched trans-NIH Big Data Knowledge Initiative https://datascience.nih.gov/bd2k). purpose this Notice to announce the NIH, through Big Data Knowledge BD2K) Initiative, collaborating a multi-agency funding opportunity, Quantitative Approaches Biomedical Big Data QuBBD) initiative http://nsf.gov/funding/pgm_summ.jsp?pims_id=505292] Recent advances medical healthcare technologies creating paradigm shift how medical practitioners biomedical researchers approach diagnosis, prevention, treatment diseases.  New imaging technologies, advances genetic testing, innovations wearable and/or ambient sensors allowing researchers predict health outcomes develop personalized treatments interventions. Coupled the rapid growth computing infrastructure, researchers have ability collect, store, analyze vast amounts health- disease-related data biological, biomedical, behavioral, social, environmental, clinical studies.  explosion the availability biomedical big data disparate sources, the complex data structures including images, networks, graphs, pose significant challenges terms visualization, modeling, analysis. While have some encouraging developments related foundational mathematical, statistical, computational approaches big data challenges over past decade, have relatively few opportunities collaboration challenges related biomedical data science.  National Science Foundation NSF) the National Institutes Health NIH) recognize fundamental questions basic, clinical, translational research benefit greatly multidisciplinary approaches involve experts quantitative disciplines such mathematics, statistics, computer science. Quantitative Approaches Biomedical Big Data Program designed support research addresses important application areas the intersection the biomedical data sciences encouraging inter- multi-disciplinary collaborations focus innovative transformative approaches address challenges. Award Information NIH expects fund projects durations up 3 years. Award sizes expected be less 200,000 direct costs) per year.  awards under Funding Opportunity Announcement FOA) NIH be grants cooperative agreements, determined the supporting agency. Application Preparation Submission Instructions Applications submitted response this FOA) should prepared submitted accordance the general guidelines contained the NSF Grant Proposal Guide GPG). Applications must submitted the NSF, to NIH. complete text the GPG available electronically the NSF website http://www.nsf.gov/publications/pub_summ.jsp?ods_key=gpg. Applicants reminded identify NSF program announcement number the program announcement block the NSF Cover Sheet Proposal the National Science Foundation. Compliance this announcement critical determining relevant application processing guidelines. Failure submit information delay processing. Budgetary Information Inclusion voluntary committed cost sharing prohibited. NIH, indirect costs foreign subawards/subcontracts be limited 8 percent. NIH Process those applications are selected potential funding the Big Data Knowledge BD2K) Program, PD/PI be required submit application an NIH-approved format. PD/PIs invited submit NIH receive further information submission procedures NIH. applicant not allowed increase proposed total budget change scientific content the application the submission the NIH an NIH application. NIH applications be entered the NIH IMPAC II system. results the review be presented the involved Institutes' National Advisory Councils the second level review. Subsequent the Council reviews, NIH make final funding determinations selected awards be made. Subsequent grant administration procedures NIH awardees, including those related New Early Stage Investigators http://www.niaid.nih.gov/researchfunding/grant/Pages/aag.aspx), be accordance the policies NIH. Applications selected NIH funding use NIH funding mechanisms. information purposes, NIH PD/PIs wish consult NIAID web site, about Grants," provides excellent generic information all aspects NIH grantsmanship http://www.niaid.nih.gov/researchfunding/grant/Pages/aag.aspx). Inquiries Please direct inquiries to: Vinay M. Pai National Institute Biomedical Imaging Bioengineering NIBIB) Telephone: 301-451-4781 Email: BD2K_QuBBD@mail.nih.gov   data science, big data, computational, informatics, statistics
Notice of NIEHS's Participation in RFA-MD-15-005 "NIH Big Data to Knowledge (BD2K) Enhancing Diversity in Biomedical Data Science (R25)" NOT-ES-15-008 NIEHS Jan 13 2015 N/A Notice NIEHS's Participation RFA-MD-15-005 NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)" Notice Number: NOT-ES-15-008 Key Dates Release Date: January 13, 2015 Related Announcements RFA-MD-15-005 Issued National Institute Environmental Health Sciences NIEHS) Purpose purpose this Notice to inform potential applicants the National Institute Environmental Health Sciences NIEHS) participation, effective immediately, the Funding Opportunity Announcement FOA), RFA-MD-15-005, entitled quot;NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)". RFA-MD-15-005 been updated the following ways reflect NIEHS' participation this FOA. Part 1. Overview Information Components Participating Organizations National Institute Minority Health Health Disparities NIMHD) National Cancer Institute NCI) National Human Genome Research Institute NHGRI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Drug Abuse NIDA) National Institute General Medical Sciences NIGMS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Library Medicine NLM) National Center Complementary Alternative Medicine NCCAM) National Center Advancing Translational Sciences NCATS) Division Program Coordination, Planning Strategic Initiatives Office Research Infrastructure Programs ORIP) Office Behavioral Social Sciences Research OBSSR) Office Strategic Coordination Common Fund) National Institute Environmental Health Sciences NIEHS) Catalog Federal Domestic Assistance CFDA) Number(s): 93.307; 93.350; 93.213; 93.398; 93.399; 93.172; 93.866; 93.273; 93.855; 93.856; 93.846; 93.286; 93.865; 93.279; 93.173; 93.121; 93.847; 93.859; 93.242; 93.853; 93.361; 93.879; 93.351; 93.310; 93.394; 93.395; 93.396; 93.397; 93.399; 93.113 Part 2. Section VII. Agency Contacts Scientific/Research Contact(s) Carol Shreffler, PhD National Institute Environmental Health Sciences NIEHS) Telephone: 919-541-1445 Email: shreffl1@niehs.nih.gov Financial/Grants Management Contact(s) Lisa Edwards, MPA National Institute Environmental Health Sciences NIEHS) Telephone: 919-541-0751 Email: archer@niehs.nih.gov Inquiries Please direct inquiries to: Carol Shreffler, PhD National Institute Environmental Health Sciences NIEHS) Telephone: 919-541-1445 Email: shreffl1@niehs.nih.gov nbsp; data science, big data
Notice of NIDCR Participation in PAR-19-380 Initiative to Maximize Research Education in Genomics: Diversity Action Plan (R25) NOT-DE-19-019 NIDCR Nov 06 2019 N/A Notice NIDCR Participation PAR-19-380 Initiative Maximize Research Education Genomics: Diversity Action Plan R25) Notice Number: NOT-DE-19-019 Key Dates Release Date: November 06, 2019 Related Announcements PAR-19-380 Issued National Institute Dental Craniofacial Research NIDCR) Purpose purpose this Notice to inform potential applicants the National Institute Dental Craniofacial Research NIDCR) participating, effective immediately, PAR-19-380 ldquo;Initiative Maximize Research Education Genomics: Diversity Action Plan R25)”. following changes been to reflect NIDCR's participation this FOA: Part 1. Overview Information following information been added: Components Participating Organizations National Institute Dental Craniofacial Research NIDCR) Catalog Federal Domestic Assistance CFDA) Numbers 93.121 Part 2. Full Text Announcement Section I. Funding Opportunity Description NIDCR interested applications enhance diversity the NIDCR dental, oral craniofacial DOC) research workforce areas genomics, genetics, bioinformatics, data science, in ethical social impact these research activities. NIDCR interests include exposing students the undergraduate, post-baccalaureate graduate levels are diverse backgrounds, including those underrepresented groups, the foundational sciences relevant DOC genomics enable to pursue careers areas are relevant the NIDCR missionand Strategic Plan. Potential applicants encouraged contact NIDCR program official discuss relevance proposed research topic(s). Section VII. Agency Contacts following contacts been added: Scientific/Research Contact(s) Lynn Mertens King, PhD Research Training Career Development Branch National Institute Dental Craniofacial Research Telephone: 301-594-5006 Email: lynn.king@nih.gov Lu Wang, PhD Translational Genomics Research Branch National Institute Dental Craniofacial Research Telephone: 301) 594-4846 Email: wanglu@mail.nih.gov Peer Review Contact Yasaman Shirazi, PhD National Institute Dental Craniofacial Research NIDCR) Telephone: 301-594-5593 Email: yasaman.shirazi@nih.gov Financial/Grants Management Contact Dede Rutberg, MBA National Institute Dental Craniofacial Research NIDCR) Telephone: 301-594-4798 Email: rutbergd@mail.nih.gov Inquiries Please direct inquiries to: Lynn Mertens King, PhD National Institute Dental Craniofacial Research Telephone: 301-594-5006 Email: lynn.king@nih.gov
Notice of NIDA Participation in PAR-20-036 "Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clini NOT-DA-20-016 NIDA Dec 05 2019 N/A Notice NIDA Participation PAR-20-036 Getting Zero: Understanding HIV Viral Suppression Transmission the United States R01 Clinical Trial Optional)" Notice Number: NOT-DA-20-016 Key Dates Release Date: December 5, 2019 Related Announcements PAR 20-036 Issued National Institute Drug Abuse NIDA) Purpose purpose this Notice to inform potential applicants the National Institute Drug Abuse NIDA) participating in PAR 20-036 "Getting Zero: Understanding HIV Viral Suppression Transmission the United States R01 Clinical Trial Optional)". following sections been updated reflect participation NIDA this FOA: Part 1. Overview Information Components Participating Organizations National Institute Allergy Infectious Diseases NIAID) National Institute Mental Health NIMH) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Drug Abuse NIDA) Catalog Federal Domestic Assistance CFDA) Number(s) 93.855; 93.242; 93.865; 93.279 Part 2. Full Text Announcement Section I. Funding Opportunity Description NIDA interested the following areas research involving people use drugs PWUD) including key populations e.g., MSM, TW, FSW, HRH) where drug is common contributing HIV risk: Studies epidemiology HIV transmission care indicators testing, transmission networks, linkage care, engagement, suppression viral load) provide methods increasing accuracy speed providing data actionable data jurisdictional national population levels particular attention role drug use  Studies provide timely evaluation HIV care, drug use, drug treatment, stratified substance and population-based factors such gender, sexual risk, race, age, geographic region. Epidemiology research understand long-term viral suppression the correlates predictors success relation patterns substance use, including injection practices. Studies provide timely evaluation HIV care, drug use, drug treatment, specific attention drug and structural features service delivery including variations policy environments, service availability, service integration financing prevention care services, including those related substance use. Research uncover novel correlates predictors initial sustained HIV viral suppression capitalizing information related contextual factors may affect suppression, including changes housing stability, transitions and of incarceration other kinds institutionalization supervision e.g., drug court, probation, parole, foster care). Research regarding role participation syringe service programs SSPs) viral suppression on participation services provide pathways viral suppression e.g., HIV testing, referral care, care adherence). Research focuses the impact stigma access utilization care success preventing treating HIV, attention stigmas related drug e.g., drug user self-stigma, stigma anticipated or enacted providers, stigma among providers around serving drug users). Implementation science research combines knowledge derived epidemiology, data science or modeling on-the-ground experiences improve viral suppression. Such research focus testing approaches identify diagnose hard-to-reach populations, strategies improve service delivery, strategies targeting structural and/or systems-level barriers service delivery ART adherence substance using populations e.g. socio-economic marginalization, stigma, incarceration, poor access substance treatment, destitution. Partnerships care implementers community key elements these studies. addition the methods noted PAR-20-036 https://grants.nih.gov/grants/guide/pa-files/PAR-20-036.html, NIDA encourages application innovative approaches including system dynamics modeling geographic information systems. of multiple sources data sources encouraged including strategies link methodologically comparable datasets utilize readily available public and administrative data. Part 2. Section VII. Agency Contacts Scientific/Research Contact(s) Richard A. Jenkins, Ph.D. National Institute Drug Abuse NIDA) Telephone: 301-443-1923 Email: jenkinsri@mail.nih.gov Financial/Grants Management Contact(s) Pam Fleming National Institute Drug Abuse NIDA) Telephone: 301-480-1159 Email: pfleming@mail.nih.gov other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Richard A. Jenkins, Ph.D. National Institute Drug Abuse NIDA) Telephone: 301-443-1923 Email: jenkinsri@mail.nih.gov
Notice of NICHD Participation in PAR-20-036 "Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clin NOT-HD-19-040 NICHD Nov 06 2019 N/A Notice NICHD Participation PAR-20-036 Getting Zero: Understanding HIV Viral Suppression Transmission the United States R01 Clinical Trial Optional)" Notice Number: NOT-HD-19-040 Key Dates Release Date: November 06, 2019 Related Announcements PAR 20-036 Issued Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Purpose purpose this Notice to inform potential applicants the Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) participating in PAR 20-036 "Getting Zero: Understanding HIV Viral Suppression Transmission the United States R01 Clinical Trial Optional)". following sections been updated reflect participation NICHD this FOA: Part 1. Overview Information Components Participating Organizations National Institute Allergy Infectious Diseases NIAID) National Institute Mental Health NIMH) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Catalog Federal Domestic Assistance CFDA) Number(s) 93.855; 93.242; 93.865 Part 2. Full Text Announcement Section I. Funding Opportunity Description NICHD particularly interested research among adolescents young adults, 12-24 years old, supports: Innovative strategies harnessing data-based epidemiology approaches related technologies improve expedite viral suppression among hard reach populations adolescents young adults are unaware are infected, repeatedly disengage re-engage care, substances suffer mental illness are unstably housed e.g. mobile engagement strategies, virtual cohorts). Improved accuracy speed describe epidemiology HIV transmission care indicators among adolescents young adults testing, transmission networks, linkage care, engagement, suppression viral load) jurisdictional national population levels Data-driven epidemiology evaluate HIV care a timely manner among adolescents young adults stratified sub-populations, such by gender, transmission risk, race, age, geographic region Data-based epidemiology approaches understand long-term viral suppression the correlates predictors success adolescents young adults Research uncover novel correlates predictors initial sustained HIV viral suppression capitalizing a rich understanding the contextual factors impacting suppression adolescents young adults: example, proportion new cases experienced change housing such unstable housing, recently aged of foster care had recent incarceration? does stigma impact access care success preventing treating HIV? components syringe substitution programs SSP)s most successful promoting testing referral HIV care? Implementation science research combines knowledge derived epidemiology, data science or modeling on-the-ground experiences improve viral suppression. Such research focus testing approaches identify diagnose hard-to-reach populations, strategies improve service delivery, strategies targeting barriers service delivery stigma. Partnerships care implementers community key elements these studies. Part 2. Section VII. Agency Contacts Scientific/Research Contact(s) Bill G. Kapogiannis, MD Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Telephone: 301-402-0698 Email: kapogiannisb@mail.nih.gov Financial/Grants Management Contact(s) Bryan S. Clark, MBA Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Telephone: 301-435-6975 Email: clark1@mail.nih.gov other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Bill G. Kapogiannis, MD Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Telephone: 301-402-0698 Email: kapogiannisb@mail.nih.gov
Notice of NICHD Participation in PAR-18-411 "Getting To Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clin NOT-HD-18-004 NICHD Feb 13 2018 N/A Notice NICHD Participation PAR 18-411 Getting Zero: Understanding HIV Viral Suppression Transmission the United States R01 Clinical Trial Allowed)" Notice Number: NOT-HD-18-004 Key Dates Release Date: February 13, 2018   Related Announcements PAR-18-411 Issued Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Purpose purpose this Notice to inform potential applicants the Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) participating PAR-18-411 Getting Zero: Understanding HIV Viral Suppression Transmission the United States R01 Clinical Trial Allowed)". following sections been updated reflect participation NICHD this FOA: Part 1. Overview Information Components Participating Organizations National Institute Allergy Infectious Diseases NIAID) National Institute Mental Health NIMH) Eunice Kennedy Shriver National Institute Child Health Human Development (NICHD) Catalog Federal Domestic Assistance CFDA) Number(s)  93.855; 93.242; 93.865 Part 2. Full Text Announcement Section I. Funding Opportunity Description NICHD particularly interested research among adolescents young adults, 12-24 years old, supports: Improved accuracy speed describe epidemiology HIV care indicators among adolescents young adults: testing, linkage, engagement, retention, ART uptake, suppression viral load a jurisdictional national population level. Evaluations the epidemiology HIV care monitor progress overall in sub-populations adolescents young adults, such by gender, transmission risk, race, age, developmental stage geographic region e.g. phylogenetic geospacial analyses HIV transmission dynamics). Research uncover novel correlates predictors initial sustained HIV viral suppression capitalizing a rich understanding the contextual factors specific adolescents young adults impacting suppression. Measurements long-term viral suppression, the correlates predictors success adolescents young adults. Implementation strategies addressing coverage, service delivery systems, barriers service delivery uptake, stigma can obtained existing data estimated modeling applications including vulnerable adolescent periods transition adult service providers. Innovative strategies harnessing Big Data Science related technologies improve expedite viral suppression among hard reach populations such adolescents are unaware are infected, repeatedly disengage re-engage care, substances suffer mental illness are unstably housed e.g. mobile engagement strategies, virtual cohorts). Part 2. Section VII. Agency Contacts Scientific/Research Contact(s) Bill G. Kapogiannis, M.D. Eunice Kennedy Shriver National Institute Child Health Human Development NICHD)  Telephone: 301-402-0698  Email: kapogiannisb@mail.nih.gov  Financial/Grants Management Contact(s) Bryan S. Clark, MBA Eunice Kennedy Shriver National Institute Child Health Human Development NICHD)   Telephone: 301-435-6975  Email: clark1@mail.nih.gov     other aspects this FOA remain unchanged.  Inquiries Please direct inquiries to: Bill G. Kapogiannis, M.D. Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Telephone: 301-402-0698  Email: kapogiannisb@mail.nih.gov data science, big data
Notice of NIBIB's Participation in RFA-HG-16-016 "BD2K RFA-HG-Open Educational Resources for Skills Development in Biomedical Big Data Science ( NOT-EB-16-007 NIBIB May 27 2016 N/A Notice NIBIB's Participation RFA-HG-16-016 BD2K Open Educational Resources Skills Development Biomedical Big Data Science R25)" Notice Number: NOT-EB-16-007 Key Dates Release Date: 27, 2016 Related Announcements RFA-HG-16-016 Issued National Institute Biomedical Imaging Bioengineering NIBIB) Purpose purpose this Notice to inform potential applicants the National Institute Biomedical Imaging Bioengineering NIBIB)'s participation, effective immediately, RFA-HG-16-016, quot;BD2K Open Educational Resources Skills Development Biomedical Big Data Science R25)". following sections RFA-HG-16-016 been updated reflect participation NIBIB this FOA: Part 1.  Overview Information Components Participating Organizations: National Human Genome Research Institute NHGRI) National Cancer Institute NCI) National Eye Institute NEI) National Institute Aging NIA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences nbsp;(NIEHS) National Institute General Medical Sciences NIGMS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Library Medicine NLM) Fogarty International Center FIC) National Center Complementary Integrative Health NCCIH) National Center Advancing Translational Sciences NCATS) Division Program Coordination, Planning Strategic Initiatives, Office Disease Prevention ODP) Division Program Coordination, Planning Strategic Initiatives Office Research Infrastructure Programs ORIP) Office Behavioral Social Sciences Research OBSSR) Office Research Women’s Health ORWH) Office Strategic Coordination Common Fund) National Institute Biomedical Imaging Bioengineering NIBIB) Catalog Federal domestic Assistance CFDA) Number(s): 93.172; 93.989; 93.350; 93.242; 93.173; 93.853; 93.398; 93.279; 93.865; 93.867; 93.846; 93.847; 93.866; 93.313; 93.879; 93.213; 93.121; 93.856; 93.855; 93.310; 93.351; 93.113 nbsp;93.286 Part 2. Section VII. Agency Contacts Scientific/Research Contact(s) Richard A. Baird, Ph.D. National Institute Biomedical imaging Bioengineering NIBIB) Telephone:   301-496-7671 Email:  bairdri@mail.nih.gov Financial/Grants Management Contacts Kwesi Wright, MBA National Institute Biomedical Imaging bioengineering NIBIB) Telephone:  301-451-4789 Email: wrightk@mail.nih.gov other aspects this FOA remain same. Inquiries Please direct inquiries to: Richard A. Baird, Ph.D. National Institute Biomedical Imaging Bioengineering NIBIB)  Telephone: 301-496-7671 Email: bairdri@mail.nih.gov data science, big data
Notice of NIBIB Participation in RFA-HG-14-007 Mentored Career Development Award in Biomedical Big Data Science for Clinicians and Doctorally Prepared NOT-EB-14-002 NIBIB Jan 17 2014 N/A Notice NIBIB Participation RFA-HG-14-007 Mentored Career Development Award Biomedical Big Data Science Clinicians Doctorally Prepared Scientists K01)" Notice Number: NOT-EB-14-002 Key Dates Release Date: January 17, 2014 Related Announcements RFA-HG-14-007 Issued National Institute Biomedical Imaging Bioengineering NIBIB) Purpose Notice to inform potential applicants National Institute Biomedical Imaging Bioengineering NIBIB) participating RFA-HG-14-007 entitled quot;Mentored Career Development Award Biomedical Big Data Science Clinicians Doctorally Prepared Scientists K01)", effective immediately.   BD2K FOA solicits K01 applications a new mentored career development award the area Big Data Science. aim the initiative to support additional training scientists will gain knowledge skills necessary be independent researchers well to work a team environment develop new Big Data technologies, methods, tools applicable basic clinical research.? following sections RFA-HG-14-007 been updated reflect participation NIBIB this FOA. Part 1. Overview Information  Components Participating Organizations National Human Genome Research Institute NHGRI) National Cancer Institute NCI) National Eye Institute NEI) National Heart, Lung, Blood Institute NHLBI) National Institute Aging NIA) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Drug Abuse NIDA) National Institute Environmental Health Sciences NIEHS) National Institute General Medical Sciences NIGMS) National Institute Mental Health NIMH) National Institute Neurological Disorders Stroke NINDS) National Institute Nursing Research NINR) National Institute Minority Health Health Disparities NIMHD) National Library Medicine NLM) National Center Complementary Alternative Medicine NCCAM) Office Behavioral Social Sciences Research OBSSR) Office Strategic Coordination Common Fund) Catalog Federal Domestic Assistance CFDA) Number(s) 93.286, 93.989; 93.350; 93.213; 93.213; 93.394; 93.395; 93.396; 93.397; 93.398; 93.399; 93.867; 93.172; 93.233; 93.837; 93.838; 93.839; 93.866; 93.273; 93.855; 93.856; 93.846; 93.865; 93.279; 93.173; 93.121; 93.847; 93.113; 93.859; 93.242; 93.307; 93.853; 93.361; 93.879; 93.351; 93.313; 93.310  nbsp; Part 2. Section VII. Agency Contacts Scientific/Research Contact(s) Zeynep Erim, PhD National Institute Biomedical Imaging Bioengineering NIBIB) Office: 301-451-4797 Email: erimz@mail.nih.gov Financial/Grants Management Contact(s) Florence Turska National Institute Biomedical Imaging Bioengineering NIBIB) Office: 301-496-9314 Email: turskaf@mail.nih.gov other aspects this FOA remain unchanged. Inquiries Please direct inquiries to: Richard A. Baird, PhD National Institute Biomedical Imaging Bioengineering NIBIB) Office: 301-496-7671  Blackberry: 240-533-1924  Email: bairdri@mail.nih.gov nbsp; data science, big data
Notice of NIAID's Participation in RFA-MD-16-002 "NIH Big Data to Knowledge (BD2K) Enhancing Diversity in Biomedical Data Science (R25)" NOT-AI-16-067 NIAID Aug 08 2016 N/A Notice NIAID's Participation RFA-MD-16-002 NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)" Notice Number: NOT-AI-16-067 Key Dates Release Date:   August 8, 2016 Related Announcements RFA-MD-16-002     Issued National Institute Allergy Infectious Diseases NIAID) Purpose Notice to inform potential applicants the National Institute Allergy Infectious Diseases NIAID) participating, effective immediately, Funding Opportunity Announcement FOA), RFA-MD-16-002 quot;NIH Big Data Knowledge BD2K) Enhancing Diversity Biomedical Data Science R25)". following sections RFA-MD-16-002 been updated reflect participation NIAID this FOA: Part 1. Overview Information Components Participating Organizations National Institute Minority Health Health Disparities NIMHD) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Deafness Other Communication Disorders NIDCD) National Institute Environmental Health Sciences NIEHS) National Center Complementary Integrative Health NCCIH) Division Program Coordination, Planning Strategic Initiatives, Office Research Infrastructure Programs ORIP) Catalog Federal Domestic Assistance CFDA) Number(s) 93.307; 93.351; 93.846; 93.213; 93.113; 93.173; 93.855; 93.856 other aspects this Funding Opportunity Announcement remain same. Inquiries Please direct inquiries to: Quan Chen, Ph.D. National Institute Allergy Infectious Diseases NIAID) Telephone: 240-627-3489 Email: quan.chen@nih.gov  data science, big data
Notice of NIAIDs Participation in PA-19-217 Administrative Supplement for Research on Bioethical Issues (Admin Supp Clinical Trial Optional)" NOT-AI-19-054 NIAID Apr 04 2019 N/A Notice NIAID’s Participation PA-19-217 Administrative Supplement Research Bioethical Issues Admin Supp Clinical Trial Optional)" Notice Number: NOT-AI-19-054 Key Dates Release Date: April 05, 2019 Related Announcements PA-19-217 NOT-OD-19-101 Issued National Institute Allergy Infectious Diseases NIAID) Purpose purpose this Notice to inform potential applicants the National Institute Allergy Infectious Diseases NIAID) participating, effective immediately, in PA-19-217 “Administrative Supplement Research Bioethical Issues Admin Supp Clinical Trial Optional)". following information shown initalics) been added: Part 1. Overview Information Components Participating Organizations National Cancer Institute NCI) National Human Genome Research Institute NHGRI) National Institute Aging NIA) National Institute Neurological Disorders Stroke NINDS) Fogarty International Center FIC) National Center Advancing Translational Sciences NCATS) National Heart, Lung, Blood Institute NHLBI) National Institute Alcohol Abuse Alcoholism NIAAA) National Institute Allergy Infectious Diseases NIAID) National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) National Institute Biomedical Imaging Bioengineering NIBIB) Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) National Institute Deafness Other Communication Disorders NIDCD) National Institute Dental Craniofacial Research NIDCR) National Institute Diabetes Digestive Kidney Diseases NIDDK) National Institute Mental Health NIMH) National Institute Minority Health Health Disparities NIMHD) National Institute Nursing Research NINR) Office Strategic Coordination Common Fund) Catalog Federal Domestic Assistance CFDA) Number(s) 93.121, 93.172, 93.173, 93.233, 93.242, 93.273, 93.286, 93.307, 93.310, 93.350, 93.361, 93.393, 93.394, 93.395, 93.396, 93.399, 93.837, 93.838, 93.839, 93.840, 93.846, 93.847, 93.853, 93.855, 93.865, 93.866, 93.989 Part 2. Full Text Announcement Section I. Funding Opportunity Description Areas Research Interest the Administrative Supplement NIH seeks fund research ethical considerations related biomedical research. issues fall within scope research policy activities the NIH may beyond focus any Institute Center. Overarching areas research interest include are limited to: New emerging technology development use, such as: gene editing; organoids; artificial intelligence; machine learning; brain implants modulation; digital health; consumer-generated data Clinical non-clinical data sharing; big data data science analytics; integration data research, including clinical, research, environment, social media, participant/patient provided, other Precision personalized medicine Personal, institutional, research privacy security Learning Healthcare System; interface clinical research clinical care; pragmatic trials Crowdsourcing, citizen science, DIY biomedical research Participant driven, directed, sponsored clinical research Patient/participant representation research oversight, including appropriate return research results incidental findings Special vulnerable population research, including pediatric, palliative care, emergency, disaster, pandemic research Individual community health, treatment, and/or research disparities; accessing sharing benefits research; post-study obligations Issues related the inclusion Tribal American Indian/Alaska Native populations Issues related the inclusion populations underrepresented research Current emerging regulatory environments Innovative study design, conduct, management, oversight, including methods obtaining documenting informed consent; virtual clinical trials International research including research resource-constrained settings, transnational research, research low middle income countries Research stigmatized conditions Historical analyses bioethics issues Novel approaches enhancing bioethics infrastructure training addition overarching areas interest, individual Institutes Centers indicated following specific areas research interest: NCI National Cancer Institute NCI) interested bioethics issues relevant cancer research care, such issues raised cancer clinical trials, cancer cohorts, cancer prevention studies, cancer centers, prospective biobanking, projects using existing samples/tissues. Bioethical issues interest include are limited issues raised new therapies/technologies; patient participant perception comprehension; patient, participant, community engagement; return results; new methods recruitment/retention hard reach” participants. Additional issues be found here:https://epi.grants.cancer.gov/bioethics-cancer-research.html. NHGRI National Human Genome Research Institute NHGRI) interested applications investigate address bioethical issues related the of genetics genomics research, clinical medicine healthcare, society. NHGRI supports studies specific conditions diseases only the proposed work produce knowledge is generalizable transferable other genetic conditions. NIA National Institute Aging NIA) interested applications address topics relevant its core mission. more information, please see:https://www.nia.nih.gov/about/mission FIC Fogarty International Center FIC) interested research ethical issues relevant low- middle-income countries, particular, studies conducted investigators these countries. NINDS National Institute Neurological Disorders Stroke NINDS) interested research bioethical neuroethical questions relevant its mission seek fundamental knowledge the brain nervous system to that knowledge reduce burden neurological disease. addition the general areas interest listed above, areas interest specific NINDS include are limited the ethical implications of: aspects neuroscience research human participants, such differing stakeholder views trial design, return research results participants, patient consent-related issues, therapeutic misconception including rare diseases); research brain organoids ex vivo human brain tissue; collecting sharing human brain data, such de-identification, privacy, re-use practices; development use neuromodulation neuroimaging technologies, such device maintenance, data security, intended unintended uses these technologies; predictive/diagnostic research related brain disorders; advances neural recording and/or neuromodulation specifically use children. Additional information the NINDS mission be found here:http://www.ninds.nih.gov/about_ninds/mission.htm. Note applications must consider bioethical and/or neuroethical questions be within general scope the parent award. Also, NINDS not consider applications include basic research activities research vertebrate animals. NCATS National Center Advancing Translational Sciences NCATS) interested research ethical issues cross disease domains span translational research spectrum. NCATS encourages collaboration between translational researchers bioethics researchers projects addressing ethical challenges moving discoveries laboratory, clinic, community interventions improve health. NIMHD National Institute Minority Health Health Disparities NIMHD) interested supporting research projects the ethical, legal, social implications research participation and/or health care racial/ethnic minority other health disparity populations. Areas interest NIMHD include are limited studies seek understand address cultural preferences; values norms ensure ethical equitable conduct research delivery health care; ethical integration social biomedical sciences e.g., social epigenomics incorporation social determinants the health care system); mitigating stigmatization, group harms, unintended social implications research. NICHD TheEunice Kennedy ShriverNational Institute Child Health Human Development NICHD) interested bioethical issues relevant research involving children, pregnant women, people disabilities. Research the fields developmental biology, reproductive health, pediatrics, population health, medical rehabilitation, research addresses health disparities improves prevention efforts among populations served NICHD, well areas identified high-priority research areas the institute of particular interest. andhttps://www.nichd.nih.gov/grants-contracts/research-areas/prioritiesfor current research priorities the institute inhttps://www.nichd.nih.gov/about/org/strategicplanregarding future themes the Institute. NHLBI National Heart, Lung, Blood Institute NHLBI) interested research bioethics issues relevant its Strategic Vision https://www.nhlbi.nih.gov/about/strategic-vision), its focus heart, lung, blood, sleep conditions. Specific examples include, are limited to: return research results e.g., genomic, omic, environmental) participants communities, such environmental toxins may impact community health, handoff between research clinical care, providing genetic counseling large scales Waivers informed consent obtaining consent surrogates Ethics cardiopulmonary support Novel emerging technologies, such machine learning bias algorithm overreach physician autonomy Privacy confidentiality especially large datasets), such artificial intelligence applied imaging data concerns may arise multi-omics profiles impact NIH policy changes, such updates the management genomic summary results Issues related working understudied vulnerable populations e.g., pregnant women, pediatric perinatal patients, Indigenous groups), such community engagement ensuring equal access research advances Investigators encouraged contact NHLBI staff discuss ideas. Investigators interested developing applications this funding opportunity announcement strongly encouraged discuss ideas specific IC contacts listed below prior submission ICs varying levels interest high priority areas. NIAAA National Institute Alcohol Abuse Alcoholism NIAAA) interested bioethics applications address topics relevant its mission research priorities provided its strategic plan. information, please see:https://www.niaaa.nih.gov/strategic-plan NIAID NIAID particularly interested supporting supplemental projects focus ethical issues relevant domestic international collaborative research HIV/AIDS its co-morbidities TB, malaria, hepatitis, sexually transmitted infections), other infectious diseases; ethics clinical trials implementation science; ethical issues relevant NIAID's scientific mission. Applications include conceptual work bioethics, empirical work gathering analyzing data relevant ethical issues research, a combination the two. empirical projects, data collection include quantitative qualitative methods, both. Although intended be exhaustive list, particular interest projects on: Ethical issues research involving adolescents young adults Ethical issues research curing HIV Ethical, legal policy issues research big data Ethics research involving child-bearing age pregnant women Applications addressing empirical research informed consent not interest. NIAMS mission The National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) to support research the causes, treatment, prevention arthritis musculoskeletal skin diseases; training basic clinical scientists carry this research; the dissemination information research progress these diseases. NIAMS also conducts supports basic research the normal structure function bones, joints, muscles, skin. Basic research involves wide variety scientific disciplines, including immunology, genetics, molecular biology, structural biology, biochemistry, physiology, virology, pharmacology. Clinical research areas include rheumatology, orthopedics, dermatology, metabolic bone diseases, heritable disorders bone cartilage, inherited inflammatory muscle diseases, sports rehabilitation medicine. NIAMS interested bioethics topics relevant its core mission. NIBIB National Institute Biomedical Imaging Bioengineering NIBIB) interested applications address topics relevant its core mission. more information, please see:https://www.nibib.nih.gov/research-funding. NIDCD National Institute Deafness Other Communications Disorders NIDCD) interested applications address topics the areas hearing, balance, taste, smell, voice, speech, language. more information, please see:NIDCD Strategic Plan. NIDCR National Institute Dental Craniofacial Research NIDCR) interested applications propose bioethics research relevant dental, oral, craniofacial health. more information, please see:https://www.nidcr.nih.gov/about-us/mission. NIDDK National Institute Diabetes Digestive Kidney Diseases NIDDK) interested applications address topics relevant its core mission. more information, please see:NIDDK Research Areas. NIMH Priority areas research include are limited bioethical considerations around privacy issues; consent capacity, agency, autonomy; of predictive analytics; safety monitoring; participant, provider, community perceptions comprehension research; issues related the engagement recruitment understudied groups; additional safety ethical considerations necessary conducting research populations risk suicide https://www.nimh.nih.gov/funding/clinical-research/conducting-research-w...). addition, bioethics new interventions technologies, biobanking approaches, use biospecimens biopreparations of interest. NINR NINR interested studies examining bioethical issues related end life palliative care EOLPC) research consider including not limited to): EOLPC needs individuals serious, advanced illness, particularly vulnerable populations such as: children, frail elderly, individuals limited decision-making capacity. Prioritization patient preferences, beliefs, values respect treatment and/or end life decision making. needs/challenges families, caregivers, proxy decision makers individuals serious, advanced illness. Disparities access EOLPC individuals across settings urban, rural, remote), including differences among socioeconomic, racial/ethnic geographic sub-populations. Because the complex, multi-factorial nature this issue, multi-disciplinary teams highly encouraged. Common Fund Office Strategic Coordination Common Fund) supported projects propose include relevant investigations Research Bioethical Issues eligible apply. Section VII. Agency Contacts Scientific/Research Contact(s) Jennifer Plank-Bazinet, Ph.D. Office Science Policy/Office the Director OSP/OD) Telephone: 301-435-8342 Email:jennifer.bazinet@nih.gov Nicole Lockhart National Human Genome Research Institute NHGRI) Telephone: 301-480-2493 Email:lockhani@mail.nih.gov Tammara Jenkins, MSN, RN, PCNS-BC Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Telephone: 301-435-6837 Email:tjenkins@mail.nih.gov Mollie Minear, Ph.D. National Heart, Lung, Blood Institute NHLBI) Telephone: 301-435-0448 Email:mollie.minear@nih.gov Aynur Unalp-Arida, MD, MSc, PhD National Institute Diabetes Digestive Kidney Diseases NIDDK) Telephone: 301-594-8879 Email:aynur.unalp-arida@nih.gov Khara Ramos, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone: 301-594-2614 Email:khara.ramos@nih.gov Barbara Sina, Ph.D. Fogarty International Center FIC) Telephone: 301-402-9467 Email:sinab@mail.nih.gov Elaine Collier, M.D. National Center Advancing Translational Sciences NCATS) Telephone: 301-435-0794 Email:colliere@mail.nih.gov Emilie Caga-Anan, J.D. National Cancer Institute NCI) Telephone: 240-276-6738 Email:charlisse.caga-anan@nih.gov Kristina McLinden, Ph.D. National Institute Aging NIA) Telephone: 301-827-2563 Email:kristina.mclinden@nih.gov Pamela Wernett, Ph.D. National Institute Alcohol Abuse Alcoholism NIAAA) Telephone: 301-827-5391 Email:wernettpj@mail.nih.gov Joana Roe National Institute Allergy Infectious Diseases NIAID) Telephone: 240-627-3213 Email: Joana.Roe@nih.gov Robyn Bent, M.S. National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Telephone: 301-827-2272 Email:robyn.bent@nih.gov Todd Merchak National Institute Biomedical Imaging Bioengineering NIBIB) Telephone: 301-496-8592 Email:merchakt@mail.nih.gov Trinh Ly, M.D. National Institute Deafness Other Communication Disorders NIDCD) Telephone: 301-496-5061 Email:trinh.ly@nih.gov Leslie Frieden, Ph.D. National Institute Dental Craniofacial Research NIDCR) Telephone: 301-496-4263 Email:leslie.frieden@nih.gov Andrea Beckel-Mitchener, Ph.D National Institute Mental Health NIMH) Telephone: 301-443-2847 Email:amitchen@mail.nih.gov Nancy Jones, Ph.D., M.A. National Institute Minority Health Disparities NIMHD) Telephone: 301-594-8945 Email:jonesna@nimhd.nih.gov Lynn Adams, Ph.D. National Institute Nursing Research NINR) Telephone: 301-594-8911 Email:adamsls@mail.nih.gov Leslie K. Derr, Ph.D. Office Strategic Coordination Common Fund) Telephone: 301-594-8174 Email:derrl@mail.nih.gov Financial/Grants Management Contact(s) Bryan Clark, MBA Eunice Kennedy Shriver National Institute Child Health Human Development NICHD) Telephone: 301-435-6975 Email:clarkb1@mail.nih.gov Eunica Haynes National Institute Diabetes Digestive Kidney Diseases NIDDK) Telephone: 301-827-4018 Email:Haynese@niddk.nih.gov Tawana McKeither National Heart, Lung, Blood Institute NHLBI) Telephone: 301-827-9238 Email:tawana.mckeither@nih.gov Tijuana Decoster, Ph.D. National Institute Neurological Disorders Stroke NINDS) Telephone 301-496-9531 Email:decostert@mail.nih.gov Monique Day, Ph.D. National Institute Biomedical Imaging Bioengineering NIBIB) Telephone: 301-451-4797 Email:Monique.day@nih.gov Bruce Butrum Fogarty International Center FIC) Telephone: 301-496-2075 Email:butrumb@mail.nih.gov Harvey Kincaid National Center Advancing Translational Sciences NCATS) Telephone: 301-435-0850 Email:harvey.kincaid@nih.gov Crystal Wolfrey National Cancer Institute NCI) Telephone: 240-276-6277 Email:wolfreyc@gab.nci.nih.gov Deanna Ingersoll National Human Genome Research Institute NHGRI) Telephone: 301-435-7858 Email:Deanna.Ingersoll@nih.gov Traci Lafferty National Institute Aging NIA) Phone: 301-496-8987 Email:laffertt@mail.nih.gov Judy Fox National Institute Alcohol Abuse Alcoholism NIAAA) Telephone: 301-443-4704 Email:jfox@mail.nih.gov Dhana Khurana National Institute Allergy Infectious Diseases NIAID) Telephone: 240-669-2966 Email: Vandhana.Khurana@nih.gov Leslie Littlejohn National Institute Arthritis Musculoskeletal Skin Diseases NIAMS) Telephone: 301-594-5055 Email:Leslie.Littlejohn@nih.gov Christopher Myers National Institute Deafness Other Communication Disorders NIDCD) Telephone: 301-435-0713 Email:myersc@mail.nih.gov Diana Rutberg, M.B.A. National Institute Dental Craniofacial Research NIDCR) Telephone: 301-594-4798 Email:rutbergd@mail.nih.gov Terri Jarosik National Institute Mental Health NIMH) Telephone: 301-443-3858 Email:theresa.jarosik@nih.gov Priscilla Grant, JD National Institute Minority Health Health Disparities NIMHD) Telephone: 301-594-8412 Email:pg38h@nih.gov Ronald Wertz National Institute Nursing Research NINR) Telephone: 301) 594-2807 Email:wertzr@mail.nih.gov Chris Darby Office Strategic Coordination Common Fund) Telephone: 301-480-1059 Email:DarbyCh@mail.nih.gov other aspects this FOA remain same. Inquiries Please direct inquiries to: Joana Roe National Institute Allergy Infectious Diseases NIAID) Telephone: 240-627-3213 Email: Joana.Roe@nih.gov data science, big data, artificial intelligence, machine learning

Pages

XLS